CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,375,000 | -64.6% | 500,000 | -66.7% | 0.09% | -76.7% |
| Q1 2020 | $9,540,000 | -47.7% | 1,500,000 | -14.3% | 0.40% | -42.8% |
| Q4 2019 | $18,244,000 | +828.4% | 1,750,000 | +250.0% | 0.70% | +792.4% |
| Q3 2019 | $1,965,000 | -45.3% | 500,000 | +150.0% | 0.08% | -40.6% |
| Q4 2018 | $3,592,000 | -21.0% | 200,000 | +100.0% | 0.13% | +37.1% |
| Q2 2018 | $4,547,000 | -65.6% | 100,000 | -60.0% | 0.10% | -41.2% |
| Q1 2018 | $13,200,000 | -22.4% | 250,000 | 0.0% | 0.16% | -35.8% |
| Q4 2017 | $17,000,000 | +79.4% | 250,000 | +117.4% | 0.26% | +57.7% |
| Q3 2017 | $9,476,000 | +304.8% | 115,000 | +360.0% | 0.16% | +297.6% |
| Q2 2017 | $2,341,000 | +5.4% | 25,000 | -50.0% | 0.04% | -16.3% |
| Q4 2016 | $2,221,000 | – | 50,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |